Danaparoid for cardiopulmonary bypass in patients with previous heparin- induced thrombocytopenia

British Journal of Haematology

Volumn 98, Issue 3, 1997, Pages 657-659

  Gillis, Shmuel ^a   Merin, Gideon ^b   Zahger, Doron ^b   Deeb, Maher ^b   Drenger, Benjamin ^b   Hyam, Esti ^b   Eldor, Amiram ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Cardiopulmonary bypass; Danaparoid; Heparin; Thrombocytopenia

Indexed keywords

ANTICOAGULANT AGENT; DANAPAROID; HEPARIN; HEPARINOID;

ADULT; ANAMNESIS; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030922774     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2633080.x     Document Type: Article

References (12)

1. Altes, A., Martino, R., Gari, M., Camara, M.L., Garin, R., Casas, J-I. & Fontcuberta, J. (1995) Heparin-induced thrombocytopenia and heart operation: management with Tedelparin. Annals of Thoracic Surgery, 59, 508-509.
2. Chong, B.H. (1995) Heparin-induced thrombocytopenia. British Journal of Haematology, 89, 421-439.
3. Doherty, D.C., Ortel, T.L., De Bruijn, N., Greenberg, C.S. & Van Trigt, P. (1990) 'Heparin-free' cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass. Anesthesiology, 73, 562-565.
4. Magnani, H.N. (1993) Heparin-induced thrombocytopenia: an overview of 230 patients treated with Orgaran (Org 10172). Thrombosis and Haemostasis, 70, 554-561.
5. Marshall, L.R., Cannell, P.K. & Herrmann, R.P. (1992) Successful use of the APTT in monitoring of the anti-factor Xa activity of the heparinoid Organon 10172 in a case of HITS requiring open heart surgery. Thrombosis and Haemostasis, 67, 587.
6. Matsuo, T., Kario, K., Chikahira, Y., Nakao, K. & Yamada, T. (1992) Treatment of heparin-induced thrombocytopenia by use of Argatroban, a synthetic thrombin inhibitor. British Journal of Haematology, 82, 627-628.
7. Ramakrishna, R., Manoharan, A., Kwan, Y.L. & Kyle, P.W. (1995) Heparin-induced thrombocytopenia: Cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran). British Journal of Haematology, 91, 736-738.
8. Rhodes, G.R., Dixon, R.H. & Silver, D. (1977) Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Annals of Surgery, 186, 752-758.
9. Rowlings, P.A., Evans, S., Mansberg, R., Murray, B. & Rozenberg, M.C. (1991) The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis. Australian and New Zealand Journal of Medicine, 21, 52-54.
10. Schiele, F., Vuillemenot, A., Kramarz, P., Kieffer, Y., Anguenot, T., Bernard, Y. & Bassand, J.P. (1995) Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia. American Journal of Hematology, 50, 20-25.
11. Teasdale, S.J., Zulys, V.J., Baird, R.J., Mycyk, T. & Glynn, M.F.X. (1989) Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis. Annals of Thoracic Surgery, 48, 712-713.
12. Wilhelm, M.J., Schmid, C., Kececioglu, D., Mollhoff, T., Osterman, H. & Scheld, H.H. (1996) Cardiopulmonary bypass in patients with heparin induced thrombocytopenia using Org 10172. Annals of Thoracic Surgery, 61, 920-924.